Sintx Technologies, Inc. (SINT): Price and Financial Metrics

Sintx Technologies, Inc. (SINT): $0.46

0.00 (0.00%)

POWR Rating

Component Grades













Add SINT to Watchlist
Sign Up

Industry: Chemicals



in industry

SINT Stock Summary

  • SINT has a market capitalization of $15,001,139 -- more than approximately only 1.68% of US stocks.
  • With a price/sales ratio of 24.75, Sintx Technologies Inc has a higher such ratio than 93.94% of stocks in our set.
  • In terms of volatility of its share price, SINT is more volatile than 94.21% of stocks we're observing.
  • If you're looking for stocks that are quantitatively similar to Sintx Technologies Inc, a group of peers worth examining would be SLS, MNDO, SLRX, HSTO, and FKWL.
  • Visit SINT's SEC page to see the company's official filings. To visit the company's web site, go to

SINT Valuation Summary

  • SINT's price/sales ratio is 91.9; this is 709.69% higher than that of the median Healthcare stock.
  • SINT's price/sales ratio has moved up 89 over the prior 92 months.
  • Over the past 92 months, SINT's price/sales ratio has gone up 89.

Below are key valuation metrics over time for SINT.

Stock Date P/S P/B P/E EV/EBIT
SINT 2021-08-31 91.9 1.6 -3.9 -1.7
SINT 2021-08-30 88.8 1.6 -3.8 -1.6
SINT 2021-08-27 90.6 1.6 -3.8 -1.6
SINT 2021-08-26 88.8 1.6 -3.8 -1.6
SINT 2021-08-25 90.6 1.6 -3.8 -1.6
SINT 2021-08-24 92.7 1.7 -3.9 -1.7

SINT Growth Metrics

    Its 3 year net cashflow from operations growth rate is now at -15.59%.
  • Its year over year net cashflow from operations growth rate is now at -4.09%.
  • The 5 year price growth rate now stands at -99.85%.
SINT's revenue has moved up $462,000 over the prior 33 months.

The table below shows SINT's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-09-30 0.557 -9.804 -8.908
2021-06-30 0.384 -9.513 -9.076
2021-03-31 0.487 -8.706 -11.112
2020-12-31 0.594 -9.112 -16.594
2020-09-30 0.729 -9.168 -15.853
2020-06-30 0.836 -8.394 -15.133

SINT's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • SINT has a Quality Grade of D, ranking ahead of 10.85% of graded US stocks.
  • SINT's asset turnover comes in at 0.013 -- ranking 167th of 186 Medical Equipment stocks.
  • NVNO, ADMT, and STAA are the stocks whose asset turnover ratios are most correlated with SINT.

The table below shows SINT's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.013 0.271 -2.184
2021-03-31 0.017 0.240 -2.313
2020-12-31 0.023 0.200 -1.316
2020-09-30 0.036 0.219 -1.030
2020-06-30 0.056 0.202 -0.759
2020-03-31 0.069 0.203 -0.258

SINT Price Target

For more insight on analysts targets of SINT, see our SINT price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $3.63 Average Broker Recommendation 1.5 (Moderate Buy)

SINT Stock Price Chart Interactive Chart >

Price chart for SINT

SINT Price/Volume Stats

Current price $0.46 52-week high $2.06
Prev. close $0.46 52-week low $0.37
Day low $0.45 Volume 55,800
Day high $0.50 Avg. volume 135,925
50-day MA $0.53 Dividend yield N/A
200-day MA $0.82 Market Cap 11.37M

Sintx Technologies, Inc. (SINT) Company Bio

Sintx Technologies, Inc. operates as a commercial biomaterial company. The Company focuses on using silicon nitride technology platform to develop, manufacture, and sell a range of medical devices, as well as markets spinal fusion products and develops products for use in total hip and knee joint replacements. Sintx Technologies serves clients in the United States.

SINT Latest News Stream

Event/Time News Detail
Loading, please wait...

SINT Latest Social Stream

Loading social stream, please wait...

View Full SINT Social Stream

Latest SINT News From Around the Web

Below are the latest news stories about Sintx Technologies Inc that investors may wish to consider to help them evaluate SINT as an investment opportunity.

SINTX Chief Scientific Officer Retires and Director of R&D Steps Into Leadership Role

SALT LAKE CITY, Dec. 31, 2021 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. ( (NASDAQ: SINT) (“SINTX” or the “Company”), an original equipment manufacturer of advanced ceramics, announced today its Chief Scientific Officer, Dr. Bryan J. McEntire, will be retiring at the end of 2021 after 17 years with the company. Dr. Ryan Bock will move into the role of Vice President of Research and Development (R&D) to take on the leadership of SINTX’s R&D activities. Following retirement, Dr. Mc

Yahoo | December 31, 2021

SINTX Technologies Provides End of Year 2021 Business Update

SALT LAKE CITY, Dec. 08, 2021 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. ( www.sint x .com ) (NASDAQ: SINT) (“SINTX” or the “Company”), an original equipment manufacturer of advanced ceramics, shared an end of the year 2021 business update including details from its biomedical, antipathogenic, and industrial business segments:

Intrado Digital Media | December 8, 2021

Vanguard Group Inc. Raises Stock Holdings in Sintx Technologies, Inc. (NASDAQ:SINT)

Vanguard Group Inc. raised its position in shares of Sintx Technologies, Inc. (NASDAQ:SINT) by 158.6% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 968,942 shares of the companys stock after acquiring an additional 594,280 shares during the period. Vanguard Group Inc. []

Transcript Daily | November 26, 2021

SINTX Technologies Provides Update on SINTX Armor

SALT LAKE CITY, Nov. 16, 2021 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. ( (NASDAQ: SINT) (“SINTX” or the “Company”), an original equipment manufacturer of advanced ceramics, provided an update today on the launch of its newly created and wholly-owned subsidiary SINTX Armor. SINTX has signed a 10-year lease on a facility near its headquarters in Salt Lake City, UT to house development and manufacturing activities for SINTX Armor. All of the equipment associated with the ceramic a

Yahoo | November 16, 2021

SINTX Technologies Ends Patent License Agreement With O2TODAY

SALT LAKE CITY, Nov. 05, 2021 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. ( ) (NASDAQ: SINT) (SINTX or the Company), an original equipment manufacturer of advanced ceramics for medical and non-medical applications, announced today that it has ended its Patent License Agreement with O2TODAY following O2TODAYs delay in bringing a product to market.

Intrado Digital Media | November 5, 2021

Read More 'SINT' Stories Here

SINT Price Returns

1-mo -8.00%
3-mo -7.91%
6-mo -47.30%
1-year -68.28%
3-year -91.14%
5-year -99.60%
YTD -28.34%
2021 -59.11%
2020 5.37%
2019 -72.41%
2018 -94.50%
2017 -56.75%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.6949 seconds.